Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Benedictuson Jul 16, 2018 7:00pm
148 Views
Post# 28324068

Added to my position

Added to my positionFrom my chart read, when the stock printed .78 last week, it was forecasting a test of the first support zone (.68 - .72). I added to my position today and will add again either at the next support (.58 - .60), or if/when news on solid revenue results gets the price back over .85.  

I see a lot of speculators/bashers on this board (I'm having to really employ that ignore feature here to damp down the "noise") and I can certainly understand a deep frustration due to management over-promising and really not delivering as of yet. My concern is not so much with short-sighted investors but whether LDS has done real damage in terms of customer/vendor relations by continually over-promising  and not delivering product. However, perhaps in the MJ biz right now there is some understanding as suppliers are coming online trying to meet all the regulations and product testing requirements. It would be great if we had any contributors on this board who work in the biz and could offer any insights?!  So, that is an additional concern on top of the biomass and lab testing bottleneck concerns. Having said all that, even the 300L contract, if finally met this month and going forward, makes this company fairly if not undervalued. And the capacity they are building, even if margins tighten quicker than expected, should still enable LDS market cap to expand rapidly, which is why when blood is in the streets, as it was in the MJ sector today, it was a good time to add.IMHO 

Best to all!
Bullboard Posts